262 related articles for article (PubMed ID: 25565005)
1. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling.
Goossens S; Radaelli E; Blanchet O; Durinck K; Van der Meulen J; Peirs S; Taghon T; Tremblay CS; Costa M; Farhang Ghahremani M; De Medts J; Bartunkova S; Haigh K; Schwab C; Farla N; Pieters T; Matthijssens F; Van Roy N; Best JA; Deswarte K; Bogaert P; Carmichael C; Rickard A; Suryani S; Bracken LS; Alserihi R; Canté-Barrett K; Haenebalcke L; Clappier E; Rondou P; Slowicka K; Huylebroeck D; Goldrath AW; Janzen V; McCormack MP; Lock RB; Curtis DJ; Harrison C; Berx G; Speleman F; Meijerink JP; Soulier J; Van Vlierberghe P; Haigh JJ
Nat Commun; 2015 Jan; 6():5794. PubMed ID: 25565005
[TBL] [Abstract][Full Text] [Related]
2. The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signaling.
Li J; Riedt T; Goossens S; Carrillo García C; Szczepanski S; Brandes M; Pieters T; Dobrosch L; Gütgemann I; Farla N; Radaelli E; Hulpiau P; Mallela N; Fröhlich H; La Starza R; Matteucci C; Chen T; Brossart P; Mecucci C; Huylebroeck D; Haigh JJ; Janzen V
Blood; 2017 Jan; 129(4):460-472. PubMed ID: 27683414
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia.
Goossens S; Peirs S; Van Loocke W; Wang J; Takawy M; Matthijssens F; Sonderegger SE; Haigh K; Nguyen T; Vandamme N; Costa M; Carmichael C; Van Nieuwerburgh F; Deforce D; Kleifeld O; Curtis DJ; Berx G; Van Vlierberghe P; Haigh JJ
Blood; 2017 Feb; 129(8):981-990. PubMed ID: 28069602
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection.
Omilusik KD; Best JA; Yu B; Goossens S; Weidemann A; Nguyen JV; Seuntjens E; Stryjewska A; Zweier C; Roychoudhuri R; Gattinoni L; Bird LM; Higashi Y; Kondoh H; Huylebroeck D; Haigh J; Goldrath AW
J Exp Med; 2015 Nov; 212(12):2027-39. PubMed ID: 26503445
[TBL] [Abstract][Full Text] [Related]
5. Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection.
van Helden MJ; Goossens S; Daussy C; Mathieu AL; Faure F; Marçais A; Vandamme N; Farla N; Mayol K; Viel S; Degouve S; Debien E; Seuntjens E; Conidi A; Chaix J; Mangeot P; de Bernard S; Buffat L; Haigh JJ; Huylebroeck D; Lambrecht BN; Berx G; Walzer T
J Exp Med; 2015 Nov; 212(12):2015-25. PubMed ID: 26503444
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.
Treanor LM; Zhou S; Janke L; Churchman ML; Ma Z; Lu T; Chen SC; Mullighan CG; Sorrentino BP
J Exp Med; 2014 Apr; 211(4):701-13. PubMed ID: 24687960
[TBL] [Abstract][Full Text] [Related]
7. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms.
Goossens S; Wang J; Tremblay CS; De Medts J; T'Sas S; Nguyen T; Saw J; Haigh K; Curtis DJ; Van Vlierberghe P; Berx G; Taghon T; Haigh JJ
Haematologica; 2019 Aug; 104(8):1608-1616. PubMed ID: 30679322
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of Mouse Enteric Nervous System Progenitor Cells Is Controlled by Endothelin 3 and Requires Regulation of Ednrb by SOX10 and ZEB2.
Watanabe Y; Stanchina L; Lecerf L; Gacem N; Conidi A; Baral V; Pingault V; Huylebroeck D; Bondurand N
Gastroenterology; 2017 Apr; 152(5):1139-1150.e4. PubMed ID: 28063956
[TBL] [Abstract][Full Text] [Related]
9. ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma.
Qi S; Song Y; Peng Y; Wang H; Long H; Yu X; Li Z; Fang L; Wu A; Luo W; Zhen Y; Zhou Y; Chen Y; Mai C; Liu Z; Fang W
PLoS One; 2012; 7(6):e38842. PubMed ID: 22761708
[TBL] [Abstract][Full Text] [Related]
10. Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice.
Caudell D; Harper DP; Novak RL; Pierce RM; Slape C; Wolff L; Aplan PD
Blood; 2010 Feb; 115(6):1194-203. PubMed ID: 20007546
[TBL] [Abstract][Full Text] [Related]
11. The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia.
Li H; Mar BG; Zhang H; Puram RV; Vazquez F; Weir BA; Hahn WC; Ebert B; Pellman D
Blood; 2017 Jan; 129(4):497-508. PubMed ID: 27756750
[TBL] [Abstract][Full Text] [Related]
12. JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL.
Benyoucef A; Haigh K; Cuddihy A; Haigh JJ
Leukemia; 2022 Dec; 36(12):2802-2816. PubMed ID: 36229595
[TBL] [Abstract][Full Text] [Related]
13. The transcription factor Zeb2 regulates development of conventional and plasmacytoid DCs by repressing Id2.
Scott CL; Soen B; Martens L; Skrypek N; Saelens W; Taminau J; Blancke G; Van Isterdael G; Huylebroeck D; Haigh J; Saeys Y; Guilliams M; Lambrecht BN; Berx G
J Exp Med; 2016 May; 213(6):897-911. PubMed ID: 27185854
[TBL] [Abstract][Full Text] [Related]
14. HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development.
de Bock CE; Demeyer S; Degryse S; Verbeke D; Sweron B; Gielen O; Vandepoel R; Vicente C; Vanden Bempt M; Dagklis A; Geerdens E; Bornschein S; Gijsbers R; Soulier J; Meijerink JP; Heinäniemi M; Teppo S; Bouvy-Liivrand M; Lohi O; Radaelli E; Cools J
Cancer Discov; 2018 May; 8(5):616-631. PubMed ID: 29496663
[TBL] [Abstract][Full Text] [Related]
15. MiR-141 targets ZEB2 to suppress HCC progression.
Wu SM; Ai HW; Zhang DY; Han XQ; Pan Q; Luo FL; Zhang XL
Tumour Biol; 2014 Oct; 35(10):9993-7. PubMed ID: 25008569
[TBL] [Abstract][Full Text] [Related]
16. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N
Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor Zeb2 regulates signaling in mast cells.
Barbu EA; Zhang J; Berenstein EH; Groves JR; Parks LM; Siraganian RP
J Immunol; 2012 Jun; 188(12):6278-86. PubMed ID: 22561153
[TBL] [Abstract][Full Text] [Related]
18. A miRNA signature associated with human metastatic medullary thyroid carcinoma.
Santarpia L; Calin GA; Adam L; Ye L; Fusco A; Giunti S; Thaller C; Paladini L; Zhang X; Jimenez C; Trimarchi F; El-Naggar AK; Gagel RF
Endocr Relat Cancer; 2013 Dec; 20(6):809-23. PubMed ID: 24127332
[TBL] [Abstract][Full Text] [Related]
19. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition.
Beltran M; Puig I; Peña C; García JM; Alvarez AB; Peña R; Bonilla F; de Herreros AG
Genes Dev; 2008 Mar; 22(6):756-69. PubMed ID: 18347095
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells.
Li H; Xu L; Li C; Zhao L; Ma Y; Zheng H; Li Z; Zhang Y; Wang R; Liu Y; Qu X
Mol Cancer; 2014 Jun; 13():136. PubMed ID: 24885194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
